Tue | Sep 21, 2021

EU plans Pfizer vaccine contract extension to 2023

Published:Wednesday | April 14, 2021 | 9:33 AM
European Commission President Ursula von der Leyen delivers a statement after a meeting of the college of commissioners at EU headquarters in Brussels, Wednesday, April 14, 2021. EU Commission chief Ursula von der Leyen announced plans Wednesday for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023. (John Thys, Pool via AP)

BRUSSELS — The head of the European Union’s executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023.

European Commission President Ursula von der Leyen said Wednesday that the EU will start negotiating to buy 1.8 billion doses of the Pfizer vaccine through 2023.

Pfizer has been a mainstay of the EU’s vaccination drive so far.

Von der Leyen expressed full confidence in the technology used for the Pfizer vaccine, which is different from the technology behind the AstraZeneca vaccine.

Pfizer plans to provide the EU with an extra 50 million doses in the second quarter of this year, on top of 200 million doses already earmarked for the bloc.

The deliveries will be especially welcomed by the EU’s 27 member nations considering supply delays and concerns about rare blood clots potentially linked to the AstraZeneca vaccine.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us @onlinefeedback@gleanerjm.com or editors@gleanerjm.com.